![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Haynes Alfred Shaik Madhu Sudhan Chatterjee Abhijit Singh M.
Publisher: Springer Publishing Company
ISSN: 0724-8741
Source: Pharmaceutical Research, Vol.20, Iss.9, 2003-09, pp. : 1485-1495
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Vandetanib for the treatment of non-small-cell lung cancer
By Wong Hui-li de Boer Richard H
Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 14, 2011-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Selective Cyclooxygenase-2 Inhibitors and Non-small Cell Lung Cancer
Current Medicinal Chemistry, Vol. 9, Iss. 21, 2002-11 ,pp. :